Search results for "Irritable Bowel Syndrome"

showing 10 items of 80 documents

Psychopharmacology treatment and psychological interventions in irritable bowel syndromel

2013

Irritable bowel syndrome (IBS) accounts for 25% of gastroenterology output practice, making it one of the most common disorders in this practice. Psychological and social factors may affect the development of this chronic disorder. Furthermore, psychiatric symptoms and psychiatric diseases are highly prevalent in this condition, but the approach to treating these is not always straightforward. As emphasized in the biopsychosocial model of IBS, with regard to the modulatory role of stress-related brain-gut interactions and association of the disease with psychological factors and emotional state, it proves useful to encourage psychopharmacological treatments and psychosocial therapies, both …

Biopsychosocial modelmedicine.medical_specialtySettore MED/09 - Medicina InternaHepatologybusiness.industryGastroenterologyAlternative medicinePsychological interventionDiseaseReview ArticleAffect (psychology)medicine.diseaseChronic disorderspsychopharmacological treatment. psychological interventions. irritable bowel diseasemedicinelcsh:Diseases of the digestive system. Gastroenterologylcsh:RC799-869PsychiatrybusinessPsychosocialIrritable bowel syndrome
researchProduct

The flesh ethanolic extract of Hylocereus polyrhizus exerts anti-inflammatory effects and prevents murine colitis

2015

IBD is a chronic disorder of the gastrointestinal tract characterized by mucosal inflammation and epithelial damage. Biologic therapy has significantly improved the course of the disease but there are still a high percentage of patients that do not respond to current therapies. We aim to determine the effects of the flesh ethanolic extract of Hylocereus polyrhizus (EH) in a mice model of colitis induced by TNBS.Balb/c mice received TNBS (175 mg/kg, 100 μl, i.r.) and six and thirty hours later were administered with EH (1 g/kg, i.p.). Mice were weighted daily and after sacrificing (2 and 4 days after TNBS) we analyzed mucosal histology, myeloperoxidase activity (MPO), the expression of pro-i…

Cactaceae0301 basic medicineColonmedicine.drug_classAnti-Inflammatory AgentsGene ExpressionInflammationPharmacologyCritical Care and Intensive Care MedicineInflammatory bowel diseaseAnti-inflammatorylaw.inventionIrritable Bowel SyndromeMice03 medical and health sciences0404 agricultural biotechnologylawmedicineAnimalsColitisFlavonoidsMice Inbred BALB CGastrointestinal tractNutrition and DieteticsEthanolbiologyPlant Extractsbusiness.industryPolyphenols04 agricultural and veterinary sciencesColitismedicine.disease040401 food sciencedigestive system diseasesDisease Models Animal030104 developmental biologyTrinitrobenzenesulfonic AcidFruitMyeloperoxidaseImmunologySystemic administrationbiology.proteinCytokinesmedicine.symptomPhytotherapybusinessPhytotherapyClinical Nutrition
researchProduct

Gluten Free Diet for the Management of Non Celiac Diseases: The Two Sides of the Coin

2020

A lifelong adherence to a gluten-free (GF) diet is currently the only treatment for Celiac disease (CD), an autoimmune disorder that arises after gluten ingestion in individuals who are genetically predisposed. The gluten intake exerts toxic effects through several pathways involving gut barrier integrity, intestinal microbiota composition and immune system stimulation. However, despite the great benefit of GF diet for CD patients, its use has been debated. Indeed, individuals who adopt this diet regime may be at risk of nutrient deficiencies. Emerging evidence supports a beneficial effect of a GF diet also for other pathological conditions, including gluten-related disorders (GRD) often as…

Celiac diseasesLeadership and Managementlcsh:MedicineHealth InformaticsReviewDisease03 medical and health sciences0302 clinical medicineImmune systemHealth Information Managementgluten-free dietSettore BIO/10 - BiochimicaDiabetes mellitusMedicineIngestionIrritable bowel syndrome030304 developmental biologychemistry.chemical_classification0303 health sciencesbusiness.industryHealth Policylcsh:Rnutritional and metabolic diseasesnon celiac diseasemedicine.diseaseGlutendigestive system diseaseschemistryglutenImmunology030211 gastroenterology & hepatologyGluten freebusinessHealthcare
researchProduct

Digestive disorders and Intestinal microbiota

2018

In the last decade, a barge body of scientific literature has suggested that specific alterations of the gut microbiota may be associated with ther development and clinical course of several gastrointestinal diseases, including irritable bowel syndrome, inflammatory bowel disease, celiac disease, gastrointestinal cancer and Clostridium difficile infection. These alterations are often referred to as “dysbiosis”, a generic term designing reduction of gut microbiota biodiversity and alterations in its composition. Here, we provide a synthetic overview of the key concepts on the relationship between intestinal microbiota and gastrointestinal diseases, focusing on the translation of these concep…

Clostridioides difficileDigestive System DiseasesLiver DiseasesIBDmicrobiomeReviewdysbiosisClostridium difficileBiodiversityDigestive System NeoplasmsInflammatory Bowel Diseasesdigestive systemGastrointestinal MicrobiomeEndotoxinsIrritable Bowel SyndromeCeliac DiseaseIntestinal AbsorptionClostridium InfectionsHumansDisease SusceptibilityActa bio-medica : Atenei Parmensis
researchProduct

DOP21 Role of P2X7 in intestinal fibrosis and inflammasome activation: Relevance in Crohn′s Disease

2021

Abstract Background Crohn’s disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract whose etiology is unknown. CD is associated with complications such as fibrosis or fistula, which cannot be pharmacologically reversed, requiring repeated surgery. Although a profibrotic effect of the P2X7 receptor has been described in some scenarios such as lung, heart and liver, its role in intestinal fibrosis has not been analysed yet. Given the crosstalk between fibrosis and inflammasome, we aim to analyze the relevance of P2X7 in intestinal fibrosis and inflammasome activation. Methods Surgical intestinal resections of CD patients and healthy ileum of carcinoma patients were obtai…

Crohn's diseasebusiness.industryGastroenterologyCaspase 1InflammasomeGeneral Medicinemedicine.diseaseInflammatory bowel diseaseFibrosisImmunologymedicineInterleukin 18ColitisbusinessIrritable bowel syndromemedicine.drugJournal of Crohn's and Colitis
researchProduct

Diagnosis of Non-Celiac Gluten Sensitivity (NCGS): The Salerno Experts’ Criteria

2015

Non-Celiac Gluten Sensitivity (NCGS) is a syndrome characterized by intestinal and extra-intestinal symptoms related to the ingestion of gluten-containing food, in subjects that are not affected by either celiac disease or wheat allergy. Given the lack of a NCGS biomarker, there is the need for standardizing the procedure leading to the diagnosis confirmation. In this paper we report experts' recommendations on how the diagnostic protocol should be performed for the confirmation of NCGS. A full diagnostic procedure should assess the clinical response to the gluten-free diet (GFD) and measure the effect of a gluten challenge after a period of treatment with the GFD. The clinical evaluation i…

Diagnosis; Non-Celiac Gluten SensitivityPediatricsmedicine.medical_specialtySettore MED/09 - Medicina InternaGlutensdiagnosislcsh:TX341-641DiseasePlaceboArticleDiet Gluten-FreeDouble-Blind MethodRating scaleSurveys and QuestionnairesHumansMedicineIntestinal MucosaIrritable bowel syndromedouble-blind placebo-controlled challengechemistry.chemical_classificationirritable bowel syndromeCross-Over StudiesNutrition and Dieteticsbusiness.industrynon-celiac gluten sensitivitygastrointestinal symptom rating scalenutritional and metabolic diseasesmedicine.diseaseGlutenCrossover studySurgerychemistryImmunoglobulin GBiomarker (medicine)businesslcsh:Nutrition. Foods and food supplyBiomarkersFood HypersensitivityWheat allergyFood ScienceDiagnosiNutrients
researchProduct

Instability of the faecal microbiota in diarrhoea-predominant irritable bowel syndrome

2013

The irritable bowel syndrome (IBS) is a functional gastrointestinal disorder with a largely unknown aetiology and a wide range of symptoms. Most cross-sectional studies carried out so far suggest subtle alterations in the structure of the intestinal microbiota that are barely reproduced, partly because of the high inter-subject variation in the community composition and disorder-specific features. We performed a longitudinal study to explore the within-subject variation in the faecal microbiota in two patients with IBS classified into the diarrhoea subtype and the healthy spouse of one of them. Faecal communities were monitored over 6-8 weeks and analysed through metagenomic and metatranscr…

DiarrheaMaleLongitudinal studyColonPhysiologyBiologyApplied Microbiology and BiotechnologyMicrobiologyMicrobiologyIrritable Bowel SyndromeFecesYoung AdultFunctional gastrointestinal disordermedicineHumansMicrobiomeIntestinal MucosaIrritable bowel syndromeAcute diarrhoeaFecesAgedBacteriaEcologyTemporal instabilityMicrobiotaMiddle Agedmedicine.diseaseDiarrheaFemalemedicine.symptomFEMS Microbiology Ecology
researchProduct

Self-reported nonceliac wheat sensitivity in an outpatient digestive endoscopy center: high frequency but insufficient medical approach.

2021

Objective: 'Self-reported wheat sensitivity' (SRWS) is a self-reported condition caused by wheat ingestion in the absence of celiac disease or wheat allergy. The aim of the study was to investigate the frequency and characteristics of SRWS in outpatients referred for digestive endoscopy. Methods: The study, performed at the University of Palermo, enrolled 496 outpatients. Results: Seven individuals (1.4%) had an already established diagnosis of celiac disease. The questionnaire was administered to the other 489 individuals: 98 subjects (20%) were SRWS, the remaining 391 served as controls (i.e. not-SRWS). SRWS patients were younger (P < 0.001), with a higher percentage of females (P = 0.…

DiarrheaMalemedicine.medical_specialtyAllergySettore MED/09 - Medicina InternaGlutensnon-celiac wheat sensitivityColonoscopydyspepsiaWheat HypersensitivityAsymptomaticEndoscopy GastrointestinalDiet Gluten-FreeIntolerancesInternal medicineOutpatientsmedicineHypersensitivityHumansendoscopygastro-esophageal refluxDepression (differential diagnoses)gluten-related diseaseirritable bowel syndromeHepatologymedicine.diagnostic_testinvestigationbusiness.industryGastroenterologymedicine.diseaseDiarrheaCeliac DiseaseGERDFemaleSelf Reportmedicine.symptombusinessWheat allergyEuropean journal of gastroenterologyhepatology
researchProduct

Gluten-Free Diet Reduces Symptoms, Particularly Diarrhea, in Patients With Irritable Bowel Syndrome and Antigliadin IgG

2021

Background & Aims Many patients with irritable bowel syndrome (IBS) perceive that their symptoms are triggered by wheat-containing foods. We assessed symptoms and gastrointestinal transit before and after a gluten-free diet (GFD) in unselected patients with IBS and investigated biomarkers associated with symptoms. Methods We performed a prospective study of 50 patients with IBS (ROME III, all subtypes), with and without serologic reactivity to gluten (antigliadin IgG and IgA), and 25 healthy subjects (controls) at a university hospital in Hamilton, Ontario, Canada, between 2012 and 2016. Gastrointestinal transit, gut symptoms, anxiety, depression, somatization, dietary habits, and microbiot…

Diarrheamedicine.medical_specialtyAbdominal painConstipationGastroenterologyIrritable Bowel SyndromeDiet Gluten-Free03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansProspective StudiesIrritable bowel syndromechemistry.chemical_classificationCrohn's diseaseHepatologybusiness.industryGastroenterologymedicine.disease3. Good healthCeliac DiseaseDiarrheachemistryImmunoglobulin G030220 oncology & carcinogenesis030211 gastroenterology & hepatologyGluten freemedicine.symptombusinessFODMAPSomatizationClinical Gastroenterology and Hepatology
researchProduct

Abincol® (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01), an oral nutraceutical, prag…

2019

Chronic intestinal disorders (CID), including inflammatory bowel disease (IBD), such as ulcerative colitis and Crohn’s disease, irritable bowel syndrome (IBS), and diverticular disease (DD), are diseases that relapse episodes. There is evidence that patients with CID have intestinal dysbiosis, so probiotics may counterbalance the impaired microbiota. Therefore, the current survey evaluated the efficacy and safety of Abincol®,an oral nutraceuticalcontaining a probiotic mixture with Lactobacillus plantarum LP01 (1 billion of living cells), Lactobacillus lactis subspecies cremoris LLC02 (800 millions of living cells), and Lactobacillus delbrueckii LDD01 (200 millions of living cells), in 3,460…

Diverticular DiseasesMaleirritable bowel syndromeLactobacillus delbrueckiiProbioticsdiverticular diseaseAdministration OralInflammatory bowel disease irritable bowel syndrome diverticular disease probiotic surveyMiddle AgedInflammatory Bowel DiseasesLactobacillusinflammatory bowel diseaseChronic DiseaseDietary SupplementsHumansFemaleOriginal ArticlesurveySelf ReportprobioticLactobacillus plantarumActa bio-medica : Atenei Parmensis
researchProduct